Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Huston

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Identification of UCB-9721 as a potent inhibitor of MyoA, the essential class XIV myosin motor of apicomplexan parasitesAnne K Snyder, Filomena Tedesco, Anne Kelsen, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> InfectionFrederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.
Plos Biology|October 2, 2020
Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction stepEmily A Bruce, Meei-Li Huang, Garrett A Perchetti, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
DIRECT RT-qPCR DETECTION OF SARS-CoV-2 RNA FROM PATIENT NASOPHARYNGEAL SWABS WITHOUT AN RNA EXTRACTION STEPEmily A Bruce, Meei-Li Huang, Garrett A Perchetti, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Evaluation of 4-Amino 2-Anilinoquinazolines against <i>Plasmodium</i> and Other Apicomplexan Parasites <i>In Vitro</i> and in a <i>P. falciparum</i> Humanized NOD-<i>scid</i> IL2Rγ<sup>null</sup> Mouse Model of MalariaPaul R Gilson, William Nguyen, William A Poole, et al.
The Journal of Infectious Diseases|February 18, 2026
Development of a current Good Manufacturing Practice-compliant Process for Producing Cryptosporidium parvum oocysts for Clinical UseRajiv S Jumani, Bryanna Thomas, Jay Lakshman, et al.
Science Translational Medicine|October 1, 2020
Bicyclic azetidines kill the diarrheal pathogen <i>Cryptosporidium</i> in mice by inhibiting parasite phenylalanyl-tRNA synthetaseSumiti Vinayak, Rajiv S Jumani, Peter Miller, et al.
The Lancet. Infectious Diseases|October 4, 2014
A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidiumWilliam Checkley, A Clinton White, Devan Jaganath, et al.
Science Translational Medicine|October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Biorxiv : the Preprint Server for Biology|June 29, 2026
Identification of UCB-9721 as a potent inhibitor of MyoA, the essential class XIV myosin motor of apicomplexan parasitesAnne K Snyder, Filomena Tedesco, Anne Kelsen, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of <i>Cryptosporidium</i> InfectionFrederick S Buckner, Ranae M Ranade, J Robert Gillespie, et al.
Plos Biology|October 2, 2020
Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction stepEmily A Bruce, Meei-Li Huang, Garrett A Perchetti, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
DIRECT RT-qPCR DETECTION OF SARS-CoV-2 RNA FROM PATIENT NASOPHARYNGEAL SWABS WITHOUT AN RNA EXTRACTION STEPEmily A Bruce, Meei-Li Huang, Garrett A Perchetti, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2018
Evaluation of 4-Amino 2-Anilinoquinazolines against <i>Plasmodium</i> and Other Apicomplexan Parasites <i>In Vitro</i> and in a <i>P. falciparum</i> Humanized NOD-<i>scid</i> IL2Rγ<sup>null</sup> Mouse Model of MalariaPaul R Gilson, William Nguyen, William A Poole, et al.
The Journal of Infectious Diseases|February 18, 2026
Development of a current Good Manufacturing Practice-compliant Process for Producing Cryptosporidium parvum oocysts for Clinical UseRajiv S Jumani, Bryanna Thomas, Jay Lakshman, et al.
Science Translational Medicine|October 1, 2020
Bicyclic azetidines kill the diarrheal pathogen <i>Cryptosporidium</i> in mice by inhibiting parasite phenylalanyl-tRNA synthetaseSumiti Vinayak, Rajiv S Jumani, Peter Miller, et al.
The Lancet. Infectious Diseases|October 4, 2014
A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidiumWilliam Checkley, A Clinton White, Devan Jaganath, et al.
Science Translational Medicine|October 23, 2024
<i>Cryptosporidium</i> lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacyNicola Caldwell, Caroline Peet, Peter Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Pageof 6